Atria Investments’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Buy |
42,126
+3,510
| +9% | +$1.04M | 0.14% | 147 |
|
|
2025
Q4 | $10.5M | Buy |
38,616
+7,848
| +26% | +$2.13M | 0.12% | 181 |
|
|
2025
Q3 | $8.31M | Buy |
30,768
+2,845
| +10% | +$774K | 0.1% | 239 |
|
|
2025
Q2 | $7.7M | Sell |
27,923
-1,568
| -5% | -$426K | 0.09% | 252 |
|
|
2025
Q1 | $7.82M | Sell |
29,491
-249
| -0.8% | -$61.4K | 0.1% | 236 |
|
|
2024
Q4 | $6.91M | Buy |
29,740
+690
| +2% | +$159K | 0.09% | 268 |
|
|
2024
Q3 | $6.41M | Sell |
29,050
-4,370
| -13% | -$904K | 0.08% | 286 |
|
|
2024
Q2 | $6.57M | Buy |
33,420
+3,125
| +10% | +$646K | 0.09% | 268 |
|
|
2024
Q1 | $6.52M | Buy |
30,295
+2,096
| +7% | +$440K | 0.09% | 270 |
|
|
2023
Q4 | $5.94M | Sell |
28,199
-439
| -2% | -$93.7K | 0.09% | 256 |
|
|
2023
Q3 | $5.73M | Buy |
28,638
+3,941
| +16% | +$783K | 0.1% | 248 |
|
|
2023
Q2 | $4.58M | Buy |
24,697
+480
| +2% | +$88.7K | 0.08% | 283 |
|
|
2023
Q1 | $4.64M | Buy |
24,217
+2,331
| +11% | +$422K | 0.09% | 284 |
|
|
2022
Q4 | $3.68M | Buy |
21,886
+587
| +3% | +$102K | 0.08% | 328 |
|
|
2022
Q3 | $3.77M | Buy |
21,299
+41
| +0.2% | +$8.1K | 0.08% | 290 |
|
|
2022
Q2 | $4.35M | Buy |
21,258
+3,219
| +18% | +$682K | 0.09% | 266 |
|
|
2022
Q1 | $4.29M | Sell |
18,039
-955
| -5% | -$224K | 0.08% | 316 |
|
|
2021
Q4 | $4.34M | Sell |
18,994
-281
| -1% | -$61.8K | 0.08% | 323 |
|
|
2021
Q3 | $3.73M | Buy |
19,275
+445
| +2% | +$90.2K | 0.07% | 340 |
|
|
2021
Q2 | $4M | Buy |
18,830
+1,889
| +11% | +$399K | 0.08% | 288 |
|
|
2021
Q1 | $3.46M | Buy |
16,941
+3,397
| +25% | +$669K | 0.08% | 304 |
|
|
2020
Q4 | $2.47M | Buy |
13,544
+2,284
| +20% | +$388K | 0.06% | 355 |
|
|
2020
Q3 | $1.88M | Sell |
11,260
-1,359
| -11% | -$229K | 0.06% | 359 |
|
|
2020
Q2 | $2.05M | Buy |
12,619
+2,006
| +19% | +$360K | 0.07% | 300 |
|
|
2020
Q1 | $1.83M | Sell |
10,613
-650
| -6% | -$129K | 0.14% | 145 |
|
|
2019
Q4 | $2.26M | Buy |
11,263
+8,669
| +334% | +$1.78M | 0.06% | 272 |
|
|
2019
Q3 | $548K | Buy |
2,594
+523
| +25% | +$109K | 0.02% | 555 |
|
|
2019
Q2 | $440K | Buy |
2,071
+318
| +18% | +$58.6K | 0.02% | 621 |
|
|
2019
Q1 | $289K | Buy |
1,753
+289
| +20% | +$51.1K | 0.01% | 716 |
|
|
2018
Q4 | $275K | Sell |
1,464
-786
| -35% | -$145K | 0.01% | 677 |
|
|
2018
Q3 | $383K | Buy |
2,250
+226
| +11% | +$38K | 0.02% | 683 |
|
|
2018
Q2 | $332K | Buy |
2,024
+264
| +15% | +$43.1K | 0.01% | 708 |
|
|
2018
Q1 | $285K | Sell |
1,760
-683
| -28% | -$109K | 0.01% | 700 |
|
|
2017
Q4 | $357K | Buy |
2,443
+103
| +4% | +$14.7K | 0.02% | 593 |
|
|
2017
Q3 | $317K | Buy |
2,340
+31
| +1% | +$3.92K | 0.02% | 591 |
|
|
2017
Q2 | $289K | Sell |
2,309
-6
| -0.3% | -$718 | 0.02% | 572 |
|
|
2017
Q1 | $275K | Buy |
2,315
+91
| +4% | +$10.9K | 0.02% | 549 |
|
|
2016
Q4 | $257K | Buy |
+2,224
| New | +$247K | 0.02% | 520 |
|
Other funds holding CME
VCM
VPM
Atria Investments's CME Position: Q1 2026 in Review
Atria Investments increased its CME Group (CME) stake by 9.1% in Q1 2026, buying an estimated $1.04M and bringing the position to 42,126 shares worth $12.4M. The position accounts for 0.14% of the portfolio, ranked #147.
Atria Investments first reported a position in CME in Q4 2016 and has held it in 38 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Atria Investments held 42,126 shares of CME Group worth $12.4M as of Q1 2026.
- Atria Investments bought 3,510 CME Group shares in Q1 2026, an estimated $1.04M.
- CME Group made up 0.14% of Atria Investments's portfolio in Q1 2026, its #147 holding.
- Atria Investments first reported a position in CME Group in Q4 2016 and has held it in 38 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.